TREATMENT TABLES Flashcards
PRURIGO NODULARIS AND LICHEN SIMPLEX CHRONICUS
Treatment Options for Pityriasis Rubra Pilaris
Treatment of Large-Plaque Parapsoriasis and Small-Plaque Parapsoriasis
Treatment of Pityriasis Lichenoides et Varioliformis Acuta and Pityriasis Lichenoides Chronica
Treatment of Lichen Nitidus
Treatment Options for Granuloma Annulare
Sarcoid Medical Therapy
Systemic Treatments for Sweet Syndrome
Treatment Options for Pyoderma Gangrenosum
Treatments for Subcorneal Pustular Dermatosis
Treatments for Granuloma Faciale
Treatment algorithm for chronic urticaria
Treatment of Cutaneous Mastocytosis
Treatment of Noncutaneous Mastocytosis Symptoms
Therapeutic Options in the Management of Epidermal Necrolysis
Darier Disease: Treatment
Hailey-Hailey Disease: Treatment
Treatment for Porokeratosis
Treatments for Paraneoplastic Pemphigus
Treatments for Bullous Pemphigoid
Treatments for Mucous Membrane Pemphigoid
Treatments for Epidermolysis Bullosa Acquisita (EBA)
Treatment options for LAD and CBDC
Therapeutic Options for Lupus Erythematosus–Specific Skin Disease
Treatment Ladder in Dermatomyositis
Recommended Therapeutic Strategies for Internal Organ Involvement in Systemic Sclerosis
Therapeutic Options for Skin Involvement in Systemic Sclerosis
Therapeutic algorithm for morphea based on existing evidence
Morphea Therapy
PSORIATIC DISEASE SPECIFIC INDICATIONS
Summary of 2015–2016 PsA management guidelines from EULAR and GRAPPA
Management of Sicca Symptoms in Sjögren Syndrome
Treatment of Acquired Perforating Dermatosis
Treatment Algorithm for Acne Vulgaris
Symptom manifestation-dependent therapy regimen in rosacea
Physical Interventions in Rosacea Therapy
Treatment of Ocular Rosacea
Select Therapeutic Strategies for Fox-Fordyce
Ratings of Select Therapies for Hidradenitis Suppurativa Based on Category of Evidence and Strength of Recommendation
Pharmacologic Treatment of Hirsutism
Treatment of Actinic Keratoses
Topical Treatments for Actinic Keratoses
Treatment of Bowen Disease
Risk Factors for the Conversion of Oral Leukoplakia into Oral Squamous Cell Carcinoma
Treatment Options for Patients Suffering from Single-System Langerhans Cell Histiocytosis
Treatment Algorithms for Mycosis Fungoides and Sézary Syndrome
Biologic Response Modifiers for the Treatment of Erythrodermic Cutaneous T-cell Lymphomas
Treatment Algorithms for Cutaneous B-Cell Lymphomas
Treatment of Nodular Pseudolymphoma
Fabry Disease
Other Potential Systemic Treatments of Chronic Skin Graft-Versus-Host Disease
Treatment of Chronic Granulomatous Disease
Topical Treatment of Oral Aphthous Ulcers
Systemic Treatments of Adamantiades–Behçet Disease
Other Systemic Treatments of Adamantiades-Behçet Disease
Treatment of Acute Kawasaki Disease
Pharmacologic Therapies for Raynaud Phenomenon
Treatment of Malignant Atrophic Papulosis (Degos Disease)
Treatment of Obstructive Peripheral Arterial Disease
Treatment of Thromboangiitis Obliterans
Treatment of Chronic Venous Insufficiency
Therapeutic Options for lymphedema
Management of Staphylococcus aureus Skin Infections
Management of Skin Infections Caused by Group A Streptococcus
Bacterial Cellulitis
Infectious Diseases Society of America 2014 Guidelines for Antimicrobial Management for Patients with Necrotizing Soft-Tissue Infections
Therapy Guidelines for Mycobacterium Tuberculosis Infections
Lepra Reactions and Management
Antibacterial Treatment of Leprosy Recommendations
Treatment of Dermatophytes
Oral Antifungal Agents
Topical Antifungal Agents
Candidiasis Treatment Algorithm
Treatment Algorithm for Cutaneous Malassezia Infections
Summary of Subcutaneous Mycoses
Treatments for Measles
Treatments for Parvovirus B19 Infections
Treatment for Epstein-Barr Virus Infectious Mononucleosis
Recommended Regimens for the Treatment of Orofacial Herpes Simplex Infections
Recommended Regimens for the Treatment of Genital Herpes Simplex Infections
Recommended Regimens for Other Herpes Cutaneous Diseases
Antiviral Treatment of Varicella in the Normal and Immunocompromised Host
Antiviral Treatment of Herpes Zoster in the Normal and Immunocompromised Host
Recommendations for the Use of Herpes Zoster Vaccines (2018 ACIP Recommendations)
Vaccination Against Smallpox Using Vaccinia Virus
Commonly Used Treatments for Cutaneous and Anogenital Warts
Centers for Disease Control and Prevention Recommendations for Treatment and Followup of Adults with Primary, Secondary, Early Latent, or Late Latent Syphilis.
Treatment options for Chancroid
Treatment of Lymphogranuloma Venereum
Treatment of Granuloma Inguinale
Prophylaxis for Gonococcal Infection in Neonates
Treatment of Localized, Uncomplicated Gonococcal Infection of the Cervix, Rectum, Pharynx, or Urethra (2015 CDC Guidelines)
Treatment of Disseminated Gonococcal Infection
Treatment of Gonococcal Infection in Neonates
Treatment of Mycoplasma Urethritis
Treatment of Chlamydia Infection
Treatment of Bacterial Vaginosis
Local Therapy Against Cutaneous Leishmaniasis
Systemic Drugs Available Against Leishmaniasis
Systemic Treatment Recommendations for Leishmaniasis
Treatment Options against African Trypanosomiasis
Treatment of Selected Helminthic Infections Causing Cutaneous Diseases
Treatment of Scabies
Treatment of Head Lice and Crab Lice
